Form 4: Korro Bio, Inc. Executive Loic A. Vincent Reports Stock Option Grant

Loic A. Vincent, Chief Scientific Officer of Korro Bio, Inc., reports the acquisition of stock options for 70,000 shares on April 1, 2025.

Summary

• Loic A. Vincent, the Chief Scientific Officer of Korro Bio, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on April 1, 2025.
• Vincent acquired stock options for 70,000 shares of Korro Bio, Inc. common stock at an exercise price of $15.95.
• The options vest as to 25% of the shares on March 31, 2026, with the remaining shares vesting in 36 equal monthly installments thereafter, contingent upon continued service.
• Following the reported transaction, Vincent directly owns derivative securities for 70,000 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices and aligns management interests with shareholders.

Positives

• The grant of stock options to the Chief Scientific Officer aligns his interests with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company's success.

Future Outlook

The vesting schedule suggests an expectation of continued service from the Chief Scientific Officer over the next several years.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in biotech companies like Korro Bio.
• Companies such as Moderna, BioNTech, and CRISPR Therapeutics also utilize stock options to incentivize their key personnel.
• The vesting schedule of 25% after one year followed by monthly installments is a typical arrangement.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the Chief Scientific Officer to contribute to the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership team.

Key Dates

Keywords

Form 4, Stock Options, Beneficial Ownership, Korro Bio, KRRO, Vincent, Loic, Chief Scientific Officer